1
|
He J, Lu H, Young L, Deng R, Callow D, Tong S, Jia X. Real-time quantitative monitoring of cerebral blood flow by laser speckle contrast imaging after cardiac arrest with targeted temperature management. J Cereb Blood Flow Metab 2019; 39:1161-1171. [PMID: 29283290 PMCID: PMC6547180 DOI: 10.1177/0271678x17748787] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Brain injury is the main cause of mortality and morbidity after cardiac arrest (CA). Changes in cerebral blood flow (CBF) after reperfusion are associated with brain injury and recovery. To characterize the relative CBF (rCBF) after CA, 14 rats underwent 7 min asphyxia-CA and were randomly treated with 6 h post-resuscitation normothermic (36.5-37.5℃) or hypothermic- (32-34℃) targeted temperature management (TTM) (N = 7). rCBF was monitored by a laser speckle contrast imaging (LSCI) technique. Brain recovery was evaluated by neurologic deficit score (NDS) and quantitative EEG - information quantity (qEEG-IQ). There were regional differences in rCBF among veins of distinct cerebral areas and heterogeneous responses among the three components of the vascular system. Hypothermia immediately following return of spontaneous circulation led to a longer hyperemia duration (19.7 ± 1.8 vs. 12.7 ± 0.8 min, p < 0.01), a lower rCBF (0.73 ± 0.01 vs. 0.79 ± 0.01; p < 0.001) at the hypoperfusion phase, a better NDS (median [25th-75th], 74 [61-77] vs. 49 [40-77], p < 0.01), and a higher qEEG-IQ (0.94 ± 0.02 vs. 0.77 ± 0.02, p < 0.001) compared with normothermic TTM. High resolution LSCI technique demonstrated hypothermic TTM extends hyperemia duration, delays onset of hypoperfusion phase and lowered rCBF, which is associated with early restoration of electrophysiological recovery and improved functional outcome after CA.
Collapse
Affiliation(s)
- Junyun He
- 1 Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Hongyang Lu
- 2 School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China
| | - Leanne Young
- 1 Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.,3 Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Ruoxian Deng
- 1 Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.,3 Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Daniel Callow
- 1 Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Shanbao Tong
- 2 School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China
| | - Xiaofeng Jia
- 1 Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.,3 Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.,4 Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, USA.,5 Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.,6 Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
| |
Collapse
|
2
|
Brown PL, Zanos P, Wang L, Elmer GI, Gould TD, Shepard PD. Isoflurane but Not Halothane Prevents and Reverses Helpless Behavior: A Role for EEG Burst Suppression? Int J Neuropsychopharmacol 2018; 21:777-785. [PMID: 29554264 PMCID: PMC6070045 DOI: 10.1093/ijnp/pyy029] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 03/04/2018] [Accepted: 03/14/2018] [Indexed: 01/10/2023] Open
Abstract
BACKGROUND The volatile anesthetic isoflurane may exert a rapid and long-lasting antidepressant effect in patients with medication-resistant depression. The mechanism underlying the putative therapeutic actions of the anesthetic have been attributed to its ability to elicit cortical burst suppression, a distinct EEG pattern with features resembling the characteristic changes that occur following electroconvulsive therapy. It is currently unknown whether the antidepressant actions of isoflurane are shared by anesthetics that do not elicit cortical burst suppression. METHODS In vivo electrophysiological techniques were used to determine the effects of isoflurane and halothane, 2 structurally unrelated volatile anesthetics, on cortical EEG. The effects of anesthesia with either halothane or isoflurane were also compared on stress-induced learned helplessness behavior in rats and mice. RESULTS Isoflurane, but not halothane, anesthesia elicited a dose-dependent cortical burst suppression EEG in rats and mice. Two hours of isoflurane, but not halothane, anesthesia reduced the incidence of learned helplessness in rats evaluated 2 weeks following exposure. In mice exhibiting a learned helplessness phenotype, a 1-hour exposure to isoflurane, but not halothane, reversed escape failures 24 hours following burst suppression anesthesia. CONCLUSIONS These results are consistent with a role for cortical burst suppression in mediating the antidepressant effects of isoflurane. They provide rationale for additional mechanistic studies in relevant animal models as well as a properly controlled clinical evaluation of the therapeutic benefits associated with isoflurane anesthesia in major depressive disorder.
Collapse
Affiliation(s)
- P Leon Brown
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland,Program in Neuroscience, University of Maryland School of Medicine, Baltimore, Maryland,University of Maryland School of Medicine, Baltimore, Maryland,Neuroscience Program, Maryland Psychiatric Research Center, Catonsville, Maryland
| | - Panos Zanos
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland
| | - Leiming Wang
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland,University of Maryland School of Medicine, Baltimore, Maryland,Neuroscience Program, Maryland Psychiatric Research Center, Catonsville, Maryland
| | - Greg I Elmer
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland,Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland,Program in Neuroscience, University of Maryland School of Medicine, Baltimore, Maryland,University of Maryland School of Medicine, Baltimore, Maryland,Neuroscience Program, Maryland Psychiatric Research Center, Catonsville, Maryland
| | - Todd D Gould
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland,Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland,Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland,Program in Neuroscience, University of Maryland School of Medicine, Baltimore, Maryland
| | - Paul D Shepard
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland,Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland,Program in Neuroscience, University of Maryland School of Medicine, Baltimore, Maryland,University of Maryland School of Medicine, Baltimore, Maryland,Neuroscience Program, Maryland Psychiatric Research Center, Catonsville, Maryland,Correspondence: Paul D. Shepard, PhD, Department of Psychiatry, Department of Pharmacology, Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD, Neuroscience Program, Maryland Psychiatric Research Center, Catonsville, MD ()
| |
Collapse
|